Companies / BridgeBio Oncology Therapeutics, Inc. / Activity
Activity — BridgeBio Oncology Therapeutics, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common Stock | $1.0K | +154 | 154 <0.01% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common Stock | $107.5K | +9K | 8,585 0.01% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | New | Common Stock | $984.5K | +110K | 110,000 0.14% of shares | low |
| Q1 2026 as of | Granahan Investment Management, LLC 13F manager | New | Common Stock | $2.07M | +231K | 231,040 0.29% of shares | low |
| Q1 2026 as of | Schroder Investment Management Group 13F manager | New | Common Stock | $2.16M | +249K | 249,161 0.31% of shares | low |